In-vitro flow assessment study of intra-saccular endovascular devices for brain aneurysm treatment: SEAL™ vs. WEB™ - Takeaways - MDSpire

In-vitro flow assessment study of intra-saccular endovascular devices for brain aneurysm treatment: SEAL™ vs. WEB™

  • By

  • Hamid Mansouri

  • Nedim Gulkaya

  • Matthew J. Gounis

  • Mohammad AlMajali

  • Amit Chaudhari

  • Darwin G. Ramirez Abreu

  • Syed F. Zaidi

  • Yazan K. Ashouri

  • Naoki Kaneko

  • Brian T. Jankowitz

  • David J. Altschul

  • Boris Pabon

  • Pervinder Bhogal

  • Thomas J. Wolfe

  • Edgard L. Pereira

  • Aamir Badruddin

  • Laila Ibrahim

  • Omid Amili

  • Osama O. Zaidat

  • June 19, 2026

  • 0 min

Share

  • 1

    The study evaluated flow dynamics of SEAL™ and WEB™-SL devices using particle image velocimetry in a patient-specific aneurysm model.

  • 2

    Mean residence time increased significantly with SEAL-BASE and SEAL-ARC compared to control and WEB-SL, indicating altered flow dynamics.

  • 3

    Vorticity strength decreased significantly with SEAL devices compared to control, highlighting their effectiveness in disrupting aneurysmal flow.

  • 4

    Velocity magnitude dropped significantly with SEAL devices compared to control and WEB-SL, with SEAL-BASE showing the greatest reduction.

  • 5

    Results suggest that SEAL configurations achieve greater flow reduction than WEB-SL, emphasizing the potential for optimizing neurointerventional devices.

Original Source(s)

Related Content